| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |